As stated earlier, Li et al. (2021) showed that DYRK1A mediates B-cell-activating factor (BAFF)-induced survival of normal B-cells, while DYRK1A deficiency lowered peripheral B-cell numbers and reduced autoimmune burden in a murine lupus paradigm. The gene discussed is DYRK1A; the disease is systemic lupus erythematosus.